img

Global Irinotecan Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Irinotecan Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Irinotecan is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.
The global Irinotecan market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Irinotecan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Irinotecan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Irinotecan is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Irinotecan include West-Ward Pharmaceuticals, Pfizer, Teva, Actiza Pharmaceutical, Getwell, Taj Pharma, Cipla and Salius, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Irinotecan, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Irinotecan by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Irinotecan market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Irinotecan market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


West-Ward Pharmaceuticals
Pfizer
Teva
Actiza Pharmaceutical
Getwell
Taj Pharma
Cipla
Salius
By Type
Irinotecan Hydrochloride Injection 40mg
Other
By Application
Colon Cancer
Rectal Cancer
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Irinotecan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Irinotecan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irinotecan sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Irinotecan Definition
1.2 Market by Type
1.2.1 Global Irinotecan Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Irinotecan Hydrochloride Injection 40mg
1.2.3 Other
1.3 Market Segment by Application
1.3.1 Global Irinotecan Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Colon Cancer
1.3.3 Rectal Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Irinotecan Sales
2.1 Global Irinotecan Revenue Estimates and Forecasts 2018-2034
2.2 Global Irinotecan Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Irinotecan Revenue by Region
2.3.1 Global Irinotecan Revenue by Region (2018-2024)
2.3.2 Global Irinotecan Revenue by Region (2024-2034)
2.4 Global Irinotecan Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Irinotecan Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Irinotecan Sales Quantity by Region
2.6.1 Global Irinotecan Sales Quantity by Region (2018-2024)
2.6.2 Global Irinotecan Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Irinotecan Sales Quantity by Manufacturers
3.1.1 Global Irinotecan Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Irinotecan Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Irinotecan Sales in 2022
3.2 Global Irinotecan Revenue by Manufacturers
3.2.1 Global Irinotecan Revenue by Manufacturers (2018-2024)
3.2.2 Global Irinotecan Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Irinotecan Revenue in 2022
3.3 Global Irinotecan Sales Price by Manufacturers
3.4 Global Key Players of Irinotecan, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Irinotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Irinotecan, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Irinotecan, Product Offered and Application
3.8 Global Key Manufacturers of Irinotecan, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Irinotecan Sales Quantity by Type
4.1.1 Global Irinotecan Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Irinotecan Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Irinotecan Sales Quantity Market Share by Type (2018-2034)
4.2 Global Irinotecan Revenue by Type
4.2.1 Global Irinotecan Historical Revenue by Type (2018-2024)
4.2.2 Global Irinotecan Forecasted Revenue by Type (2024-2034)
4.2.3 Global Irinotecan Revenue Market Share by Type (2018-2034)
4.3 Global Irinotecan Price by Type
4.3.1 Global Irinotecan Price by Type (2018-2024)
4.3.2 Global Irinotecan Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Irinotecan Sales Quantity by Application
5.1.1 Global Irinotecan Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Irinotecan Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Irinotecan Sales Quantity Market Share by Application (2018-2034)
5.2 Global Irinotecan Revenue by Application
5.2.1 Global Irinotecan Historical Revenue by Application (2018-2024)
5.2.2 Global Irinotecan Forecasted Revenue by Application (2024-2034)
5.2.3 Global Irinotecan Revenue Market Share by Application (2018-2034)
5.3 Global Irinotecan Price by Application
5.3.1 Global Irinotecan Price by Application (2018-2024)
5.3.2 Global Irinotecan Price Forecast by Application (2024-2034)
6 North America
6.1 North America Irinotecan Sales by Company
6.1.1 North America Irinotecan Revenue by Company (2018-2024)
6.1.2 North America Irinotecan Sales Quantity by Company (2018-2024)
6.2 North America Irinotecan Market Size by Type
6.2.1 North America Irinotecan Sales Quantity by Type (2018-2034)
6.2.2 North America Irinotecan Revenue by Type (2018-2034)
6.3 North America Irinotecan Market Size by Application
6.3.1 North America Irinotecan Sales Quantity by Application (2018-2034)
6.3.2 North America Irinotecan Revenue by Application (2018-2034)
6.4 North America Irinotecan Market Size by Country
6.4.1 North America Irinotecan Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Irinotecan Revenue by Country (2018-2034)
6.4.3 North America Irinotecan Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Irinotecan Sales by Company
7.1.1 Europe Irinotecan Sales Quantity by Company (2018-2024)
7.1.2 Europe Irinotecan Revenue by Company (2018-2024)
7.2 Europe Irinotecan Market Size by Type
7.2.1 Europe Irinotecan Sales Quantity by Type (2018-2034)
7.2.2 Europe Irinotecan Revenue by Type (2018-2034)
7.3 Europe Irinotecan Market Size by Application
7.3.1 Europe Irinotecan Sales Quantity by Application (2018-2034)
7.3.2 Europe Irinotecan Revenue by Application (2018-2034)
7.4 Europe Irinotecan Market Size by Country
7.4.1 Europe Irinotecan Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Irinotecan Revenue by Country (2018-2034)
7.4.3 Europe Irinotecan Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Irinotecan Sales by Company
8.1.1 China Irinotecan Sales Quantity by Company (2018-2024)
8.1.2 China Irinotecan Revenue by Company (2018-2024)
8.2 China Irinotecan Market Size by Type
8.2.1 China Irinotecan Sales Quantity by Type (2018-2034)
8.2.2 China Irinotecan Revenue by Type (2018-2034)
8.3 China Irinotecan Market Size by Application
8.3.1 China Irinotecan Sales Quantity by Application (2018-2034)
8.3.2 China Irinotecan Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Irinotecan Sales by Company
9.1.1 APAC Irinotecan Sales Quantity by Company (2018-2024)
9.1.2 APAC Irinotecan Revenue by Company (2018-2024)
9.2 APAC Irinotecan Market Size by Type
9.2.1 APAC Irinotecan Sales Quantity by Type (2018-2034)
9.2.2 APAC Irinotecan Revenue by Type (2018-2034)
9.3 APAC Irinotecan Market Size by Application
9.3.1 APAC Irinotecan Sales Quantity by Application (2018-2034)
9.3.2 APAC Irinotecan Revenue by Application (2018-2034)
9.4 APAC Irinotecan Market Size by Region
9.4.1 APAC Irinotecan Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Irinotecan Revenue by Region (2018-2034)
9.4.3 APAC Irinotecan Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Irinotecan Sales by Company
10.1.1 Middle East, Africa and Latin America Irinotecan Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Irinotecan Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Irinotecan Market Size by Type
10.2.1 Middle East, Africa and Latin America Irinotecan Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Irinotecan Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Irinotecan Market Size by Application
10.3.1 Middle East, Africa and Latin America Irinotecan Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Irinotecan Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Irinotecan Market Size by Country
10.4.1 Middle East, Africa and Latin America Irinotecan Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Irinotecan Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Irinotecan Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 West-Ward Pharmaceuticals
11.1.1 West-Ward Pharmaceuticals Company Information
11.1.2 West-Ward Pharmaceuticals Overview
11.1.3 West-Ward Pharmaceuticals Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 West-Ward Pharmaceuticals Irinotecan Products and Services
11.1.5 West-Ward Pharmaceuticals Irinotecan SWOT Analysis
11.1.6 West-Ward Pharmaceuticals Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Pfizer Irinotecan Products and Services
11.2.5 Pfizer Irinotecan SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Teva Irinotecan Products and Services
11.3.5 Teva Irinotecan SWOT Analysis
11.3.6 Teva Recent Developments
11.4 Actiza Pharmaceutical
11.4.1 Actiza Pharmaceutical Company Information
11.4.2 Actiza Pharmaceutical Overview
11.4.3 Actiza Pharmaceutical Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Actiza Pharmaceutical Irinotecan Products and Services
11.4.5 Actiza Pharmaceutical Irinotecan SWOT Analysis
11.4.6 Actiza Pharmaceutical Recent Developments
11.5 Getwell
11.5.1 Getwell Company Information
11.5.2 Getwell Overview
11.5.3 Getwell Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Getwell Irinotecan Products and Services
11.5.5 Getwell Irinotecan SWOT Analysis
11.5.6 Getwell Recent Developments
11.6 Taj Pharma
11.6.1 Taj Pharma Company Information
11.6.2 Taj Pharma Overview
11.6.3 Taj Pharma Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Taj Pharma Irinotecan Products and Services
11.6.5 Taj Pharma Irinotecan SWOT Analysis
11.6.6 Taj Pharma Recent Developments
11.7 Cipla
11.7.1 Cipla Company Information
11.7.2 Cipla Overview
11.7.3 Cipla Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Cipla Irinotecan Products and Services
11.7.5 Cipla Irinotecan SWOT Analysis
11.7.6 Cipla Recent Developments
11.8 Salius
11.8.1 Salius Company Information
11.8.2 Salius Overview
11.8.3 Salius Irinotecan Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Salius Irinotecan Products and Services
11.8.5 Salius Irinotecan SWOT Analysis
11.8.6 Salius Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Irinotecan Value Chain Analysis
12.2 Irinotecan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irinotecan Production Mode & Process
12.4 Irinotecan Sales and Marketing
12.4.1 Irinotecan Sales Channels
12.4.2 Irinotecan Distributors
12.5 Irinotecan Customers
13 Market Dynamics
13.1 Irinotecan Industry Trends
13.2 Irinotecan Market Drivers
13.3 Irinotecan Market Challenges
13.4 Irinotecan Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Irinotecan Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Irinotecan Hydrochloride Injection 40mg
Table 3. Major Manufacturers of Other
Table 4. Global Irinotecan Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Irinotecan Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Irinotecan Revenue Market Share by Region (2018-2024)
Table 8. Global Irinotecan Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Irinotecan Revenue Market Share by Region (2024-2034)
Table 10. Global Irinotecan Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 11. Global Irinotecan Sales by Region (2018-2024) & (MT)
Table 12. Global Irinotecan Sales Market Share by Region (2018-2024)
Table 13. Global Irinotecan Sales by Region (2024-2034) & (MT)
Table 14. Global Irinotecan Sales Market Share by Region (2024-2034)
Table 15. Global Irinotecan Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 16. Global Irinotecan Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Irinotecan Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Irinotecan Revenue Share by Manufacturers (2018-2024)
Table 19. Global Irinotecan Price by Manufacturers 2018-2024 (USD/Kg)
Table 20. Global Key Players of Irinotecan, Industry Ranking, 2021 VS 2022
Table 21. Global Irinotecan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Irinotecan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irinotecan as of 2022)
Table 23. Global Key Manufacturers of Irinotecan, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Irinotecan, Product Offered and Application
Table 25. Global Key Manufacturers of Irinotecan, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 28. Global Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 29. Global Irinotecan Sales Quantity Share by Type (2018-2024)
Table 30. Global Irinotecan Sales Quantity Share by Type (2024-2034)
Table 31. Global Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Irinotecan Revenue Share by Type (2018-2024)
Table 34. Global Irinotecan Revenue Share by Type (2024-2034)
Table 35. Irinotecan Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Irinotecan Price Forecast by Type (2024-2034) & (USD/Kg)
Table 37. Global Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 38. Global Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 39. Global Irinotecan Sales Quantity Share by Application (2018-2024)
Table 40. Global Irinotecan Sales Quantity Share by Application (2024-2034)
Table 41. Global Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Irinotecan Revenue Share by Application (2018-2024)
Table 44. Global Irinotecan Revenue Share by Application (2024-2034)
Table 45. Irinotecan Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Irinotecan Price Forecast by Application (2024-2034) & (USD/Kg)
Table 47. North America Irinotecan Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Irinotecan Sales Quantity by Company (2018-2024) & (MT)
Table 49. North America Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 50. North America Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 51. North America Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 54. North America Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 55. North America Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Irinotecan Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Irinotecan Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Irinotecan Sales Quantity by Country (2018-2024) & (MT)
Table 61. North America Irinotecan Sales Quantity by Country (2024-2034) & (MT)
Table 62. Europe Irinotecan Sales Quantity by Company (2018-2024) & (MT)
Table 63. Europe Irinotecan Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 65. Europe Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 66. Europe Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 69. Europe Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 70. Europe Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Irinotecan Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Irinotecan Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Irinotecan Sales Quantity by Country (2018-2024) & (MT)
Table 76. Europe Irinotecan Sales Quantity by Country (2024-2034) & (MT)
Table 77. China Irinotecan Sales Quantity by Company (2018-2024) & (MT)
Table 78. China Irinotecan Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 80. China Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 81. China Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 84. China Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 85. China Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Irinotecan Sales Quantity by Company (2018-2024) & (MT)
Table 88. APAC Irinotecan Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 90. APAC Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 91. APAC Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 94. APAC Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 95. APAC Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Irinotecan Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Irinotecan Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Irinotecan Sales Quantity by Region (2018-2024) & (MT)
Table 101. APAC Irinotecan Sales Quantity by Region (2024-2034) & (MT)
Table 102. Middle East, Africa and Latin America Irinotecan Sales Quantity by Company (2018-2024) & (MT)
Table 103. Middle East, Africa and Latin America Irinotecan Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Irinotecan Sales Quantity by Type (2018-2024) & (MT)
Table 105. Middle East, Africa and Latin America Irinotecan Sales Quantity by Type (2024-2034) & (MT)
Table 106. Middle East, Africa and Latin America Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Irinotecan Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Irinotecan Sales Quantity by Application (2018-2024) & (MT)
Table 109. Middle East, Africa and Latin America Irinotecan Sales Quantity by Application (2024-2034) & (MT)
Table 110. Middle East, Africa and Latin America Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Irinotecan Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Irinotecan Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Irinotecan Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Irinotecan Sales Quantity by Country (2018-2024) & (MT)
Table 116. Middle East, Africa and Latin America Irinotecan Sales Quantity by Country (2024-2034) & (MT)
Table 117. West-Ward Pharmaceuticals Company Information
Table 118. West-Ward Pharmaceuticals Description and Overview
Table 119. West-Ward Pharmaceuticals Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 120. West-Ward Pharmaceuticals Irinotecan Product and Services
Table 121. West-Ward Pharmaceuticals Irinotecan SWOT Analysis
Table 122. West-Ward Pharmaceuticals Recent Developments
Table 123. Pfizer Company Information
Table 124. Pfizer Description and Overview
Table 125. Pfizer Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 126. Pfizer Irinotecan Product and Services
Table 127. Pfizer Irinotecan SWOT Analysis
Table 128. Pfizer Recent Developments
Table 129. Teva Company Information
Table 130. Teva Description and Overview
Table 131. Teva Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 132. Teva Irinotecan Product and Services
Table 133. Teva Irinotecan SWOT Analysis
Table 134. Teva Recent Developments
Table 135. Actiza Pharmaceutical Company Information
Table 136. Actiza Pharmaceutical Description and Overview
Table 137. Actiza Pharmaceutical Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 138. Actiza Pharmaceutical Irinotecan Product and Services
Table 139. Actiza Pharmaceutical Irinotecan SWOT Analysis
Table 140. Actiza Pharmaceutical Recent Developments
Table 141. Getwell Company Information
Table 142. Getwell Description and Overview
Table 143. Getwell Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 144. Getwell Irinotecan Product and Services
Table 145. Getwell Irinotecan SWOT Analysis
Table 146. Getwell Recent Developments
Table 147. Taj Pharma Company Information
Table 148. Taj Pharma Description and Overview
Table 149. Taj Pharma Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 150. Taj Pharma Irinotecan Product and Services
Table 151. Taj Pharma Irinotecan SWOT Analysis
Table 152. Taj Pharma Recent Developments
Table 153. Cipla Company Information
Table 154. Cipla Description and Overview
Table 155. Cipla Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 156. Cipla Irinotecan Product and Services
Table 157. Cipla Irinotecan SWOT Analysis
Table 158. Cipla Recent Developments
Table 159. Salius Company Information
Table 160. Salius Description and Overview
Table 161. Salius Irinotecan Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 162. Salius Irinotecan Product and Services
Table 163. Salius Irinotecan SWOT Analysis
Table 164. Salius Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Irinotecan Distributors List
Table 168. Irinotecan Customers List
Table 169. Irinotecan Market Trends
Table 170. Irinotecan Market Drivers
Table 171. Irinotecan Market Challenges
Table 172. Irinotecan Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Irinotecan Product Picture
Figure 2. Global Irinotecan Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Irinotecan Market Share by Type in 2022 & 2034
Figure 4. Irinotecan Hydrochloride Injection 40mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Irinotecan Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Irinotecan Market Share by Application in 2022 & 2034
Figure 8. Colon Cancer
Figure 9. Rectal Cancer
Figure 10. Irinotecan Report Years Considered
Figure 11. Global Irinotecan Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Irinotecan Revenue 2018-2034 (US$ Million)
Figure 13. Global Irinotecan Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Irinotecan Sales Quantity 2018-2034 (MT)
Figure 15. Global Irinotecan Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Irinotecan Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Irinotecan Sales Quantity YoY (2018-2034) & (MT)
Figure 18. North America Irinotecan Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Irinotecan Sales Quantity YoY (2018-2034) & (MT)
Figure 20. Europe Irinotecan Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Irinotecan Sales Quantity YoY (2018-2034) & (MT)
Figure 22. China Irinotecan Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Irinotecan Sales Quantity YoY (2018-2034) & (MT)
Figure 24. APAC Irinotecan Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Irinotecan Sales Quantity YoY (2018-2034) & (MT)
Figure 26. Middle East, Africa and Latin America Irinotecan Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Irinotecan Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Irinotecan Revenue in 2022
Figure 29. Irinotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Irinotecan Revenue Market Share by Type (2018-2034)
Figure 32. Global Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Irinotecan Revenue Market Share by Application (2018-2034)
Figure 34. North America Irinotecan Revenue Market Share by Company in 2022
Figure 35. North America Irinotecan Sales Quantity Market Share by Company in 2022
Figure 36. North America Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Irinotecan Revenue Market Share by Type (2018-2034)
Figure 38. North America Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Irinotecan Revenue Market Share by Application (2018-2034)
Figure 40. North America Irinotecan Revenue Share by Country (2018-2034)
Figure 41. North America Irinotecan Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Irinotecan Sales Quantity Market Share by Company in 2022
Figure 45. Europe Irinotecan Revenue Market Share by Company in 2022
Figure 46. Europe Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Irinotecan Revenue Market Share by Type (2018-2034)
Figure 48. Europe Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Irinotecan Revenue Market Share by Application (2018-2034)
Figure 50. Europe Irinotecan Revenue Share by Country (2018-2034)
Figure 51. Europe Irinotecan Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 53. France Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 57. China Irinotecan Sales Quantity Market Share by Company in 2022
Figure 58. China Irinotecan Revenue Market Share by Company in 2022
Figure 59. China Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Irinotecan Revenue Market Share by Type (2018-2034)
Figure 61. China Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Irinotecan Revenue Market Share by Application (2018-2034)
Figure 63. APAC Irinotecan Sales Quantity Market Share by Company in 2022
Figure 64. APAC Irinotecan Revenue Market Share by Company in 2022
Figure 65. APAC Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Irinotecan Revenue Market Share by Type (2018-2034)
Figure 67. APAC Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Irinotecan Revenue Market Share by Application (2018-2034)
Figure 69. APAC Irinotecan Revenue Share by Region (2018-2034)
Figure 70. APAC Irinotecan Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 75. India Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Irinotecan Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Irinotecan Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Irinotecan Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Irinotecan Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Irinotecan Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Irinotecan Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Irinotecan Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Irinotecan Revenue Share by Country (2018-2034)
Figure 84. Brazil Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Irinotecan Revenue (2018-2034) & (US$ Million)
Figure 89. Irinotecan Value Chain
Figure 90. Irinotecan Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed